Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin
about
Drug interactions and the evolution of antibiotic resistance.Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.Reduced levofloxacin susceptibility in clinical respiratory isolates of Haemophilus influenzae is not yet associated with mutations in the DNA gyrase and topoisomerase II genes in Korea.Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulationContributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.Mutant selection window hypothesis updated.Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseQuinolones: action and resistance updated.The Inactivation of intrinsic antibiotic resistance determinants widens the mutant selection window for quinolones in Stenotrophomonas maltophilia.Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.Wicked: The untold story of ciprofloxacin.Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
P2860
Q33792926-AEFCE05F-07B6-484F-A55D-6EA80E607ABCQ34077142-B98A7070-65C5-44F9-8F8F-A0DD0410E1FFQ34474574-3656B377-BB36-45BC-8FEB-1307DF39ADB7Q34922753-28E8788F-DF9E-4224-915D-0B813C3DC02BQ35644095-4BF2E86F-1E6D-4775-8E8D-79892FF74ACAQ36295431-EEA6112D-4B9C-4A94-A193-FD266BC13367Q36728061-F1345D4B-143F-467B-84A3-CC0C0D7CC635Q37023332-42011F8D-4E0C-4A6A-AE77-CC9C3A4F2E93Q37595559-7FA38222-8206-44D7-B398-5253BD11A04EQ41183869-301D2119-0768-4702-AEC4-2A1874C8FEE8Q41454301-841022B1-5BCA-4192-BF70-847F3B5D313EQ41873346-176C70D9-FBDC-4F15-97C0-47690A739441Q48575528-4FB2A886-EBAB-4D85-83BA-10BB7FEBE4E9Q55215658-3C40C656-2261-40D9-ACA7-1F8E24A0E06AQ58756032-9C03B01B-CF20-48C2-B34B-3E3275946906
P2860
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Quinolone-resistant Haemophilu ...... levofloxacin, and moxifloxacin
@en
Quinolone-resistant Haemophilu ...... evofloxacin, and moxifloxacin.
@nl
type
label
Quinolone-resistant Haemophilu ...... levofloxacin, and moxifloxacin
@en
Quinolone-resistant Haemophilu ...... evofloxacin, and moxifloxacin.
@nl
prefLabel
Quinolone-resistant Haemophilu ...... levofloxacin, and moxifloxacin
@en
Quinolone-resistant Haemophilu ...... evofloxacin, and moxifloxacin.
@nl
P2093
P2860
P1476
Quinolone-resistant Haemophilu ...... levofloxacin, and moxifloxacin
@en
P2093
Carl M Urban
James J Rahal
Karl Drlica
Noriel Mariano
Xinying Li
P2860
P304
P356
10.1128/AAC.48.11.4460-4462.2004
P407
P577
2004-11-01T00:00:00Z